Abstract: Compounds of the formula I in which R1, X and n have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.
Type:
Grant
Filed:
May 30, 2014
Date of Patent:
September 5, 2017
Assignee:
Marck Patent GmbH
Inventors:
Hans-Peter Buchstaller, Dieter Dorsch, Christina Esdar, Birgitta Leuthner
Abstract: Compounds of the formula I in which R1, X and n have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.
Type:
Application
Filed:
May 30, 2014
Publication date:
November 3, 2016
Applicant:
Marck Patent GmbH
Inventors:
Hans-Peter BUCHSTALLER, Dieter DORSCH, Christina ESDAR, Birgitta LEUTHNER